BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15357189)

  • 1. An evaluation of the AAPM-TG43 dosimetry protocol for I-125 brachytherapy seed.
    Mobit P; Badragan I
    Phys Med Biol; 2004 Jul; 49(14):3161-70. PubMed ID: 15357189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Validation of calculation method for dose distribution around radioactive iodine-125 particles based on AAPM TG43 report].
    Tian SQ; Wang JJ; Ji Z; Jiang YL; Qiu B; Fan JH; Sun HT
    Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):199-204. PubMed ID: 36649991
    [No Abstract]   [Full Text] [Related]  

  • 4. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
    Kennedy RM; Davis SD; Micka JA; DeWerd LA
    Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo and experimental derivation of TG43 dosimetric parameters for CSM-type Cs-137 sources.
    Pérez-Calatayud J; Granero D; Casal E; Ballester F; Puchades V
    Med Phys; 2005 Jan; 32(1):28-36. PubMed ID: 15719951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
    Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
    Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose perturbation effects in prostate seed implant brachytherapy with I-125.
    Mobit P; Badragan I
    Phys Med Biol; 2004 Jul; 49(14):3171-8. PubMed ID: 15357190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
    Monroe JI; Williamson JF
    Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo Dosimetry of the 60Co BEBIG High Dose Rate for Brachytherapy.
    Campos LT; de Almeida CE
    PLoS One; 2015; 10(9):e0139032. PubMed ID: 26418559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of GPUMCD for low-energy brachytherapy seed dosimetry.
    Hissoiny S; Ozell B; Després P; Carrier JF
    Med Phys; 2011 Jul; 38(7):4101-7. PubMed ID: 21859010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of a collapsed cone dose calculation algorithm for HDR Ir-192 of APBI treatments.
    Terribilini D; Vitzthum V; Volken W; Frei D; Loessl K; van Veelen B; Manser P; Fix MK
    Med Phys; 2017 Oct; 44(10):5475-5485. PubMed ID: 28750134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry of the 198Au source used in interstitial brachytherapy.
    Dauffy LS; Braby LA; Berner BM
    Med Phys; 2005 Jun; 32(6):1579-88. PubMed ID: 16013717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BrachyGuide: a brachytherapy-dedicated DICOM RT viewer and interface to Monte Carlo simulation software.
    Pantelis E; Peppa V; Lahanas V; Pappas E; Papagiannis P
    J Appl Clin Med Phys; 2015 Jan; 16(1):5136. PubMed ID: 25679171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.